The incapability of ctDNA to seek somatic BRCA1/2 mutations might result from the spatial and temporal heterogeneity of somatic BRCA1/2 mutations in a patient’s tumour and the rare chances of ovarian cancer to disseminate through the vasculature in contrast to most other types of carcinomas [36–38]. The gene discussed is BRCA1; the disease is carcinoma.